Junxin Li, PhD, MS, RN, FAAN


Clinical Utility of Neurofilament Light in Older Adults With Sleep Disorders: Junxin Li, PhD, MS, RN, FAAN

The associate professor at Johns Hopkins School of Nursing provided insight on a presentation at SLEEP 2023, and whether neurofilament light should be more considered when assessing elderly patients with sleep disorders. [WATCH TIME: 5 minutes]

Gwen Zeigler, DO


Health Care Avoidance and Neurological Needs in Transgender and Gender-Diverse Patients

Transgender and gender-diverse patients have unique neurological considerations, but often, neurologists are unaware of the needs that are specific to this community.

David Vossler, MD


David Vossler, MD: Treating Generalized Tonic-Clonic Seizures

The Medical Director of The Neuroscience Institute at UW Medicine Valley Medical Center discussed the landscape of therapy for tonic-clonic seizures and how lacosamide might fit into the paradigm.

Sílvia Porta, PhD


Promising Therapeutic Developments for TDP-Related Pathologies: Sílvia Porta, PhD

The research assistant professor, pathology and laboratory medicine, University of Pennsylvania, talked about the ongoing research in her lab on understanding the mechanisms and consequences of TDP-43 aggregation in Alzheimer Disease. [WATCH TIME: 4 minutes]

Lisanne Dommershuijsen, MSc


Takeaways From MDS 2021: Lisanne Dommershuijsen, MSc

Following her presentation at MDS 2021, the PhD candidate in epidemiology at Erasmus University Medical Center discussed highlights from this year’s virtual congress. [WATCH TIME: 2 minutes]

Ricardo Alonso MD, MSc


A Neurological Perspective on Lessons from the COVID-19 Pandemic in NMOSD: Lorna Galleguillos, MD; Ricardo Alonso MD, MSc

The neuroimmunologist at Clínica Alemana de Santiago and head of the University Center for Multiple Sclerosis at Ramos Mejía Hospital discussed Latin American efforts to understand neuromyelitis optica spectrum disorder during the COVID-19 pandemic. [WATCH TIME: 5 minutes]

Russell Lonser, MD


Recent Progress in Advancing Gene Therapy for Parkinson Disease: Russell Lonser, MD

The director for the Gene Therapy Institute at The Ohio State University talked about the latest developments in gene therapy for patients with Parkinson disease. [WATCH TIME: 4 minutes]

Patricia C. Dugan, MD


Narrowing the Treatment Gap and Raising Awareness of Surgical Options for Epilepsy: Patricia C. Dugan, MD

The associate professor of neurology at NYU Grossman School of Medicine talked about the need for increased awareness in the medical community to address the underutilization of surgical interventions for refractory focal epilepsy. [WATCH TIME: 4 minutes]

Andrea Synowiec, DO


The Interconnected Reality of Neurologic and Psychiatric Disorders in Migraine: Andrea S. Synowiec, DO, FAAN

The system vice chair for the department of neurology at Allegheny Health Network talked about the growing evidence emphasizing the need for a more holistic approach to patient care in migraine. [WATCH TIME: 4 minutes]

Abby Rogers, DMSc, PA-C, MPAS


High-Efficacy Disease-Modifying Therapies for Multiple Sclerosis

Jason Freeman, MD, MBA, and Abby Rogers, DMSc, PA-C, MPAS, discuss a study presented at ACTRIMS 2023 on high-efficacy disease-modifying therapies for treatment-naïve patients with multiple sclerosis. Sponsored by Novartis.

Alvin Wang, DO, BC-EMS


The Benefits of Mobile Stroke Units: Alvin Wang, DO, BC-EMS

The chief of emergency medical services at Jefferson Health spoke about the operation of the Jefferson mobile stroke unit in the field, and the impact that the onset of the COVID-19 pandemic had on launching the program. [WATCH TIME: 3 minutes]

Prashant A. Natteru, MBBS, MD


Unravel the Mysteries of Multiple Sclerosis Mimics

Despite the diagnosis of MS improving, misdiagnosis remains a challenge, pointing to the need for proper differential diagnosis and mimic identification.

Melinda Magyari, MD


Unpacking the Controversy of Hormone Therapy in Multiple Sclerosis: Melinda Magyari, MD

The neurologist in the Danish Multiple Sclerosis Center at Copenhagen University Hospital discussed the debate surrounding the use of hormone therapy in multiple sclerosis treatment, highlighting the need for more clinical evidence to support its use. [WATCH TIME: 5 minutes]

Jill Dehlin, RN


Treating Patients With Migraine

What physicians in the community need to know about treating patients with migraine in community settings, and resources that can help locate certified headache specialists or other migraine specialists for referral.

Evelyn Sbar, MD


Building Your Acute Migraine Toolbox

Plagued by a long history of under- and inadequate treatment, clinicians have more options than ever to craft a personalized, effective plan for their patients.

Abhishek Lenka, MD, PhD


Managing Nonmotor Symptoms: Psychosis in Parkinson Disease

Psychosis is estimated to affect more than half of patients with Parkinson disease, and there is a growing need for improved management and therapeutic development.

Adam Naj, PhD


Collaborative Efforts for Health Equity in Alzheimer Disease Genetic Research: Adam Naj, PhD

The genetic epidemiologist at the University of Pennsylvania discussed a recent study that highlighted the importance of diverse samples in genetic research for Alzheimer disease in helping to uncover hidden genetic risk factors. [WATCH TIME: 2 minutes]

Steven Vernino, MD, PhD


AUPN Leadership Minute Episode 5: Planning a Faculty Retreat

Episode 5 of the AUPN Leadership Minute features Alissa Willis, MD, of University of Mississippi Medical Center; and Steven Vernino, MD, PhD, of UT Southwestern Medical Center. [WATCH TIME: 4 minutes]

Jinsy A. Andrews, MD, MSc


AUPN Leading Edge Episode 6: Transitioning From Academics to Industry and Vice Versa

AUPN Leading Edge Episode 6 features John D. England, MD, FAAN, and Jinsy Andrews, MD, MSc, who discuss the experiences, opportunities, and challenges while transitioning between academia and industry. [LISTEN TIME: 33 minutes]

Bijan Nejadnik, MD


Stem Cell Therapy Studies in TBI and Stroke: Bijan Nejadnik, MD

The chief medical officer at SanBio discussed how the investigational agent SB623 is being studied in TBI and stroke, with future planned studies in Alzheimer disease.

Aristide Merola, MD, PhD


Advanced Parkinson Disease: Looking Ahead

Panelists look ahead in the management of advanced Parkinson disease and discuss the promise of different investigational therapies.

Masahito Kawabori, MD, PhD


Stem Cell Therapy for TBI: Masahito Kawabori, MD, PhD

The associate professor at Hokkaido University and investigator of STEMTRA also discussed other efforts in stroke, Alzheimer disease, and Parkinson disease.

Ilya Kister, MD


Greatest Recent Advancements in MS, Looking Toward the Future: Ilya Kister, MD

The professor of neurology at the NYU Grossman School of Medicine provided his thoughts on the most notable strides within the multiple sclerosis field in the past year. [WATCH TIME: 3 minutes]

Katie Abouzahr, MD


Understanding the Therapeutic Potential of Nipocalimab: Katie Abouzahr, MD

The vice president, Autoantibody Portfolio and Maternal Fetal Immunology Disease Area Leader, Johnson & Johnson, provided perspective on the unique molecular structure of nipocalimab seen across nonclinical and clinical studies. [WATCH TIME: 3 minutes]

Gunter Hoglinger, MD


Mechanistic Approach Behind AMX0035 in Progressive Supranuclear Palsy: Gunter Hoglinger, MD

The professor of neurology and translational neuroscientist at Ludwig-Maximillian’s University Munich detailed the logic behind the ORION study, a new trial assessing AMX0035, an approved therapy for ALS, in patients with progressive supranuclear palsy. [WATCH TIME: 4 minutes]

Lianrui Zuo, MSE


Enhancing Consistency in Neuroimaging With AI and Image Harmonization: Lianrui Zuo, MSE

The PhD student in the department of electrical and computer engineering at Johns Hopkins University discussed the use of artificial intelligence and image harmonization techniques to address the challenges caused by multisite effects in neuroimaging. [WATCH TIME: 4 minutes]

Jay Alberts, PhD


Challenges With Assessing Stages of Parkinson Disease and the Lack of Standardized Biomarkers: Jay Alberts, PhD

The Edward F. and Barbara A. Bell Endowed Chair at Cleveland Clinic discussed the complexities with identifying viable biomarkers for Parkinson disease, as well as interventions geared toward specific regions of the brain. [WATCH TIME: 4 minutes]

Jan Brandes, MD, MS


Attracting More Women to Neurology: Jan Brandes, MD, MS

The assistant clinical professor at Vanderbilt University School of Medicine discussed ways of incorporating and encouraging women physicians to enter the neurology specialty. [WATCH TIME: 4 minutes]

Julienne Verdi


Successes and Advances in Migraine Care Through Headache on the Hill: Julienne Verdi

The executive director of the Alliance for Headache Disorders Advocacy discussed some of the successes from recent Headache on the Hills, and the expansion in centers of excellence for veterans with migraine. [WATCH TIME: 6 minutes]

© 2024 MJH Life Sciences

All rights reserved.